CYP3A4*22 and bleeding risk in ticagrelor users (2024)

First Author: Asiimwe I
Attributed to:  Multimorbidity Mechanism and Therapeutics Research Collaborative funded by SPF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcpt.13977

PubMed Identifier: 38163812

Publication URI: http://europepmc.org/abstract/MED/38163812

Type: Journal Article/Review

Parent Publication: Basic & Clinical Pharmacology & Toxicology

Issue: 3

ISSN: 1742-7835